Cargando…
Arguments in favour of remdesivir for treating SARS-CoV-2 infections
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135364/ https://www.ncbi.nlm.nih.gov/pubmed/32147516 http://dx.doi.org/10.1016/j.ijantimicag.2020.105933 |
| _version_ | 1783518039697784832 |
|---|---|
| author | Ko, Wen-Chien Rolain, Jean-Marc Lee, Nan-Yao Chen, Po-Lin Huang, Ching-Tai Lee, Ping-Ing Hsueh, Po-Ren |
| author_facet | Ko, Wen-Chien Rolain, Jean-Marc Lee, Nan-Yao Chen, Po-Lin Huang, Ching-Tai Lee, Ping-Ing Hsueh, Po-Ren |
| author_sort | Ko, Wen-Chien |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7135364 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. and International Society of Chemotherapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71353642020-04-08 Arguments in favour of remdesivir for treating SARS-CoV-2 infections Ko, Wen-Chien Rolain, Jean-Marc Lee, Nan-Yao Chen, Po-Lin Huang, Ching-Tai Lee, Ping-Ing Hsueh, Po-Ren Int J Antimicrob Agents Article Elsevier B.V. and International Society of Chemotherapy. 2020-04 2020-03-06 /pmc/articles/PMC7135364/ /pubmed/32147516 http://dx.doi.org/10.1016/j.ijantimicag.2020.105933 Text en © 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Ko, Wen-Chien Rolain, Jean-Marc Lee, Nan-Yao Chen, Po-Lin Huang, Ching-Tai Lee, Ping-Ing Hsueh, Po-Ren Arguments in favour of remdesivir for treating SARS-CoV-2 infections |
| title | Arguments in favour of remdesivir for treating SARS-CoV-2 infections |
| title_full | Arguments in favour of remdesivir for treating SARS-CoV-2 infections |
| title_fullStr | Arguments in favour of remdesivir for treating SARS-CoV-2 infections |
| title_full_unstemmed | Arguments in favour of remdesivir for treating SARS-CoV-2 infections |
| title_short | Arguments in favour of remdesivir for treating SARS-CoV-2 infections |
| title_sort | arguments in favour of remdesivir for treating sars-cov-2 infections |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135364/ https://www.ncbi.nlm.nih.gov/pubmed/32147516 http://dx.doi.org/10.1016/j.ijantimicag.2020.105933 |
| work_keys_str_mv | AT kowenchien argumentsinfavourofremdesivirfortreatingsarscov2infections AT rolainjeanmarc argumentsinfavourofremdesivirfortreatingsarscov2infections AT leenanyao argumentsinfavourofremdesivirfortreatingsarscov2infections AT chenpolin argumentsinfavourofremdesivirfortreatingsarscov2infections AT huangchingtai argumentsinfavourofremdesivirfortreatingsarscov2infections AT leepinging argumentsinfavourofremdesivirfortreatingsarscov2infections AT hsuehporen argumentsinfavourofremdesivirfortreatingsarscov2infections |